Federal Health Grants

Ryan White HIV/AIDS Program (RWHAP) Data Integration, Systems, and Quality Technical Assistance (DISQ) is a national training and technical assistance (T/TA) program to support RWHAP recipients and subrecipients. It funds activities to increase access to high-quality HIV care and support services for low-income people with HIV in the United States. The DISQ program develops and disseminates T/TA to help RWHAP recipients and subrecipients develop and implement data collection activities related to HIV care. This program will improve RWHAP recipients and subrecipients capacity to meet data-related program requirements and help them use data to make their programs more efficient and effective. We will award one cooperative agreement to a technical assistance provider. This provider will be responsible for on-site and virtual T/TA to RWHAP recipients and subrecipients.

This funding opportunity provides financial support to organizations that will establish a national training center to enhance the skills and capabilities of family planning service providers across the United States.

The Supporting Fetal Alcohol Spectrum Disorders (FASD) Screening and Intervention program helps reduce alcohol use during pregnancy and improves outcomes for children with FASD nationwide, especially in communities where theres a high rate of binge drinking during pregnancy. The program focuses on educating Primary Care Providers (PCPs) and increasing the use of screening, intervention, and referral processes for high-risk pregnancies. The programs goals include increasing PCPs knowledge of the risks of drinking alcohol during pregnancy as well as promoting recommended screenings, interventions, and referral approaches. In addition, PCPs who provide health care to children and adolescents will develop skills to identify and manage FASD, with a particular emphasis on fostering effective communication with families. Through recruitment, education, and technical assistance, the program aims to make lasting positive changes. Engaging a minimum of 80 practices over 5 years, the Supporting FASD Screening and Intervention program strives for widespread impact, particularly in communities that have high rates of binge drinking during pregnancy, including rural areas and medically underserved communities.

This funding opportunity is designed to support researchers investigating the connections between HIV/AIDS and various health issues related to diabetes, digestive, kidney, and metabolic diseases, particularly focusing on the complications and social factors affecting people living with HIV.

The "Engineering Durable HIV Vaccine Responses (ENDURE)" grant aims to fund research that explores the factors influencing the longevity of vaccine responses, with a focus on HIV, in order to improve vaccine design and development, and to devise better methods for measuring long-term immune responses.

This funding opportunity provides resources to state and local governments, as well as tribal organizations, to train first responders and community members in preventing opioid overdoses and improving access to treatment and recovery services, particularly in rural and tribal areas.

This funding opportunity supports collaborative research centers focused on advancing vaccine development and improving diagnostic and therapeutic approaches for Valley fever, targeting multidisciplinary teams from various eligible institutions in the U.S.

This Funding Opportunity Announcement (FOA) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This FOA provides resources for assessing the feasibility, acceptability, and utility of these approaches, in addition to usual trial preparation activities.

This funding opportunity supports research into the long-term health effects experienced by World Trade Center survivors, particularly focusing on vulnerable populations and a range of emerging health conditions.

This funding opportunity supports research projects that utilize existing cancer epidemiology cohort data to investigate important questions about cancer prevention, treatment, and survivorship, particularly for underserved populations and rare cancers.

The National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and studies aimed at prevention of progression to clinical disease and preservation of insulin production. The TNCC participates in ongoing studies and intervention trials as well as the design and conduct of new studies and intervention trials. The TNCC will: (1) support a wide range of research projects in varying stages of development, implementation and completion, and (2) provide data and sample management, including standardized acquisition, quality control, dissemination and public accessibility. The TNCC will be responsible for network administration and operations, including the evaluation, selection, and funding (through subcontracts) of Clinical Centers and central support units (such as laboratories) necessary for the conduct of TrialNets clinical studies. The TNCC PD/PI will be a voting member of the TrialNet Executive and Steering Committees, contributing to network leadership. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. This NOFO will utilize the U01 activity code. Details of the planned NOFO are provided below.

RFI Number: 7200AA24RFI00017Issuance Date: April 22, 2024Closing Date: May 20, 2024 5:00pm EDTSubject: Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)To All Interested Respondents/Parties:The United States Agency for International Development (USAID) Bureau for Global Health (GH) is publishing this Request for Information (RFI) to obtain information and input that will be used to help make planning decisions. It may inform the design of future activities related to accelerating HIV vaccine research and development in low- and middle-income countries.This RFI is issued solely to collect expert inputs for information-gathering and planning purposes. This RFI does not constitute a Notice of Funding Opportunity (NOFO) or a Request for Proposals (RFP).Please also note the following:(a) responding to this Notice will not give any advantage to any organization or individual for any subsequent competition;(b) proprietary information should not be sent;(c) responses are not offers/applications and cannot be accepted by the U.S. Government to form a binding contract/award;(d) responses to this RFI are strictly voluntary, and USAID will not pay respondents for information provided in response to this RFI;(e) USAID reserves the right to, or not to, incorporate any/some/none of the comments received from RFI into subsequent solicitations or design documents and(f) applications or resumes will be discarded and should therefore not be included in your response.USAID posts its competitive business opportunities on www.sam.gov and www.grants.gov. This RFI does not restrict the Governments approach to a future solicitation or NOFO. It is the potential responders responsibility to monitor the site for the release of any further information.Questions regarding this announcement will not be accepted or answered. Not responding to this request does not preclude participation in any future solicitation, if any is issued. No basis for claims against the U.S. Government shall arise as a result of a response to this request for information or from the U.S. Governments use of such information.Submission Instructions:Only electronic submissions will be accepted. Responses to this RFI must be written in English.Respondents will only receive an electronic confirmation acknowledging receipt of their response; theywill not receive individualized feedback on any suggestions.USAID is requesting the public to submit short submissions outlining recommendations or otherinformation pertinent to the questions noted below. Responses should note the question numberaddressed and clearly relate back to the questions listed below, but responses do not need to addressevery question listed. All responses should provide sufficient detail and justification explaining why acertain recommendation is offered. Please also provide your name, title, organization, and contactinformation in the response.All submissions must adhere to the following format to ensure an efficient review: Must be written in English, size 11 Calibri font, not to exceed 20 pages total. The graphics subtextmay use a smaller font size. Submission file should be in PDF or Microsoft Word format. Submission file should be saved as ;lt;Entitys name;gt; Response to RFI 7200AA24RFI00017. The subject line for the submission email subject line must include Response to USAID/GHs RFI- Accelerating HIV Vaccine Research and Development in LMIC Must be submitted to Ms. Simone Cho at scho@usaid.gov with a copy to Mr. Elton Fortson atefortson@usaid.gov by the closing date and time noted at the beginning of this letter.Thank you for your interest in responding to this RFI. To learn more about partnering with USAID, pleasevisit www.work with usaid.gov.

This funding opportunity supports innovative research projects aimed at understanding and addressing multiple sclerosis, targeting both established and early-career investigators from various organizations.

Not available

This funding opportunity provides up to $1 million to a wide range of organizations to develop a centralized resource for exploring and analyzing single-cell genomics data from the human brain, enhancing research on brain health and disease.

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes. The goal of this FOA is to support proof of concept studies for feasibility and exploratory development. Feasibility must not have already been developed in the literature or with preliminary data. While unpublished data are not permitted, references and data from widely available preprints that have a Digital Object Identifier (DOI) are acceptable. Investigators who have generated unpublished preliminary data should submit a proposal to companion R01.

This funding opportunity provides financial support to federally recognized Indian tribes and Alaska Native villages for projects that improve housing, infrastructure, and economic development, primarily benefiting low- and moderate-income individuals.

This funding opportunity supports researchers with a strong background in promoting diversity, equity, inclusion, and accessibility in biomedical fields, enabling them to conduct scientific research while advancing DEIA initiatives within the academic and scientific communities.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated efficacy clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies. Information about the mission and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/)

This grant provides financial support for early-career researchers from diverse backgrounds to establish independent cancer research careers, particularly those planning to lead clinical trials.